The Ratings Game: Moderna stock rally fades as analysts weigh in on what U.S. government supply deal means for COVID-19 vaccine pricing

This post was originally published on this site

The rally in Moderna Inc. shares sparked by news late Tuesday that the U.S. government has ordered 100 million doses of its COVID-19 vaccine candidate dissipated on Wednesday, as analysts weighed in on what the order means for pricing.